Modulation of Bone-Specific Tissue Regeneration by Incorporating Bone Morphogenetic Protein and Controlling the Shell Thickness of Silk Fibroin/Chitosan/Nanohydroxyapatite Core–Shell Nanofibrous Membranes
Source abstract
Abstract
The presence of both osteoconductive and osteoinductive factors is important in promoting stem cell differentiation toward the osteogenic lineage. In this study, we prepared silk fibroin/chitosan/nanohydroxyapatite/bone morphogenetic protein-2 (SF/CS/nHAP/BMP-2, SCHB2) nanofibrous membranes (NFMs) by incorporating BMP-2 in the core and SF/CS/nHAP as the shell layer of a nanofiber with two different shell thicknesses (SCHB2-thick and SCHB-thin). The physicochemical properties of SCHB2 membranes were characterized and compared with those of SF/CS and SF/CS/nHAP NFMs. When tested in release studies, the release rate of BMP-2 and the concentration of BMP-2 in the release medium were higher for SCHB2-thin NFMs because of reduced shell thickness. The BMP-2 released from the nanofiber retained its osteoinductive activity toward human-bone-marrow-derived mesenchymal stem cells (hMSCs). Compared with SF/CS and SF/CS/nHAP NFMs, the incorporation of BMP-2-promoted osteogenic differentiation of hMSCs and the SCHB-thin NFM is the best scaffold during in vitro cell culture. Gene expression analysis by real-time quantitative polymerase chain reaction detected the evolution of both early and late marker genes of bone formation. The relative mRNA expression is in accordance with the effect of BMP-2 incorporation and shell thickness, while the same was reconfirmed through the quantification of bone marker protein osteocalcin. In vivo experiments were carried out by subcutaneously implanting hMSC-seeded SCHB2-thin NFMs and acellular controls on the back sides of nude mice. Immunohistochemical and histological staining confirmed ectopic bone formation and osteogenesis of hMSCs in SCHB2-thin NFMs. In conclusion, the SCHB2-thin NFM could be suggested as a promising scaffold for bone tissue engineering.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Electrospun Nanofibers in Biomedical Applications · Periodontal Regeneration and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemical and Materials Engineering, Chang Gung University, Kwei-San, Taoyuan 333, Taiwan Republic of China
Department of Plastic and Reconstructive Surgery, Chang Gung Memorial Hospital, Chang Gung University, College of Medicine, Kwei-San, Taoyuan 333, Taiwan Republic of China
Funding
Chang Gung Memorial Hospital · National Science Council, Taiwan, Republic of China
References (40)
Show source-provided references
1. 10.1126/science.849352910.1126/science.8493529 ↗
2. 10.1016/j.mser.2014.04.00110.1016/j.mser.2014.04.001 ↗
3. 10.1016/S1672-6529(09)60211-010.1016/S1672-6529(09)60211-0 ↗
4. 10.1016/j.biotechadv.2012.10.00310.1016/j.biotechadv.2012.10.003 ↗
5. 10.1016/j.ijbiomac.2014.07.00810.1016/j.ijbiomac.2014.07.008 ↗
6. 10.1023/B:ABME.0000017544.36001.8e10.1023/B:ABME.0000017544.36001.8e ↗
7. 10.2147/IJN.S6196410.2147/IJN.S61964 ↗
8. 10.1016/j.addr.2014.11.01810.1016/j.addr.2014.11.018 ↗
9. 10.1016/j.medengphy.2015.01.00410.1016/j.medengphy.2015.01.004 ↗
10. 10.1016/j.biomaterials.2006.01.03910.1016/j.biomaterials.2006.01.039 ↗
11. 10.1016/j.colsurfb.2013.04.02810.1016/j.colsurfb.2013.04.028 ↗
12. 10.1097/TA.0b013e3181e12b5610.1097/TA.0b013e3181e12b56 ↗
13. 10.1080/10601325.2012.64220810.1080/10601325.2012.642208 ↗
14. 10.1007/s13770-012-0022-810.1007/s13770-012-0022-8 ↗
15. 10.1016/j.jmbbm.2014.10.01510.1016/j.jmbbm.2014.10.015 ↗
16. 10.1080/09205063.2013.84663310.1080/09205063.2013.846633 ↗
17. 10.1016/j.biomaterials.2011.04.06110.1016/j.biomaterials.2011.04.061 ↗
18. 10.1007/s40204-014-0026-710.1007/s40204-014-0026-7 ↗
19. 10.1016/S0266-3538(03)00178-710.1016/S0266-3538(03)00178-7 ↗
20. 10.1016/j.actbio.2013.06.04610.1016/j.actbio.2013.06.046 ↗
21. 10.1016/j.carbpol.2014.04.09410.1016/j.carbpol.2014.04.094 ↗
22. 10.1016/j.biomaterials.2006.01.02210.1016/j.biomaterials.2006.01.022 ↗
23. 10.1016/j.progpolymsci.2007.05.01310.1016/j.progpolymsci.2007.05.013 ↗
24. 10.1177/088391150606045510.1177/0883911506060455 ↗
25. 10.1016/j.biomaterials.2006.07.00810.1016/j.biomaterials.2006.07.008 ↗
26. 10.2147/IJN.S7378010.2147/IJN.S73780 ↗
27. 10.1016/0955-0674(92)90110-X10.1016/0955-0674(92)90110-X ↗
28. 10.1002/jbm.b.3285410.1002/jbm.b.32854 ↗
29. 10.1100/tsw.2008.16310.1100/tsw.2008.163 ↗
30. 10.1002/app.1992.07045102010.1002/app.1992.070451020 ↗
31. 10.1166/jnn.2007.52010.1166/jnn.2007.520 ↗
32. 10.1016/j.colsurfb.2011.03.03810.1016/j.colsurfb.2011.03.038 ↗
33. 10.1016/j.actbio.2011.11.00210.1016/j.actbio.2011.11.002 ↗
34. 10.1016/j.polymer.2009.06.05810.1016/j.polymer.2009.06.058 ↗
35. Peppas N. A. · Pharm. Acta Helv. · 1985 · 60 · 110
36. 10.1002/jbm.a.3014610.1002/jbm.a.30146 ↗
37. 10.1002/mabi.20090016910.1002/mabi.200900169 ↗
38. 10.1089/ten.tea.2008.005710.1089/ten.tea.2008.0057 ↗
39. 10.1016/j.carbpol.2013.01.06810.1016/j.carbpol.2013.01.068 ↗
40. 10.1016/j.biomaterials.2008.10.05410.1016/j.biomaterials.2008.10.054 ↗